☆ 4.6 Article

Clinical neutrophil-associated genes as reliable predictors of hepatocellular carcinoma

FRONTIERS IN GENETICS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Gastroenterology & Hepatology

The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma

Romain Donne et al.

Summary: The liver is a common site for primary cancer and a major cause of cancer death. Hepatocellular carcinoma (HCC) accounts for the majority of liver cancers. Immune-checkpoint inhibitors have shown promise in the treatment of HCC, but further understanding of the tumor microenvironment and the development of additional biomarkers are needed. Other immune-targeting strategies are also being developed. This review provides an overview of the HCC immune microenvironment and current immunotherapies.

HEPATOLOGY (2023)

添加到收藏夹

Review Medicine, Research & Experimental

Hepatocellular Carcinoma Immunotherapy

Rubens Copia Sperandio et al.

Summary: Hepatocellular carcinoma (HCC) is a common primary liver malignancy and a leading cause of cancer-related death. Single-agent anti-PD-1 immune checkpoint inhibitors (ICIs) showed initial promise, but failed to demonstrate efficacy in phase III trials. The combination of atezolizumab and bevacizumab has been approved as first-line therapy, showing significant improvements in response rate, progression-free survival, and overall survival compared to standard treatments. Ongoing clinical trials are evaluating the use of ICIs in combination with other drugs.

ANNUAL REVIEW OF MEDICINE (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Neutrophils as potential therapeutic targets in hepatocellular carcinoma

Daniel Geh et al.

Summary: The success of atezolizumab plus bevacizumab treatment has led to a shift towards combination therapies in the treatment of hepatocellular carcinoma (HCC) that include cancer immunotherapies. The focus of cancer immunotherapy has primarily been on immune checkpoints, but emerging evidence supports the role of neutrophils as important contributors to the development and progression of HCC. Neutrophil-targeted therapies are now being explored in clinical trials and may have therapeutic benefits, including enhancing the effectiveness of conventional immunotherapy.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Emerging immunotherapy or HCC: A guide for hepatologists

Friedrich Foerster et al.

Summary: HCC is one of the most common and deadliest cancers globally. Immuno-oncology has shown promising results in the treatment of HCC, with immune checkpoint inhibition becoming the first-line therapy for advanced cases. However, challenges remain in determining the role of immunotherapy in earlier stages of HCC and identifying treatment strategies for non-responsive patients.

HEPATOLOGY (2022)

添加到收藏夹

Article Oncology

Clinical M2 Macrophage-Related Genes Can Serve as a Reliable Predictor of Lung Adenocarcinoma

Chaojie Xu et al.

Summary: This study comprehensively analyzed the role of M2 macrophages in tumor progression, identified two genes strongly correlated with LUAD prognosis, and constructed a prognostic nomogram with good performance. HRG patients were suitable for new ICI immunotherapy, while LRG was more suitable for CTLA4-immunosuppressive therapy alone.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Clinical Eosinophil-Associated Genes can Serve as a Reliable Predictor of Bladder Urothelial Cancer

Chaojie Xu et al.

Summary: This study reveals the significant role of infiltrating eosinophils in tumor progression and immunotherapy of bladder urothelial carcinoma (BLCA). Candidate modules and hub genes associated with eosinophils were identified through weighted gene co-expression network analysis (WGCNA), and a risk score model based on eosinophil-related genes was developed. The results demonstrate that this risk score model can serve as a reliable predictor for the prognosis of BLCA patients and has important implications for immunotherapy and chemotherapy drug sensitivity.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

添加到收藏夹

Article Oncology

PCDH17 is regulated by methylation of DNMT3B and affects the malignant biological behavior of HCC through EMT

Yan Liu et al.

Summary: Low expression of PCDH17 is correlated with poor prognosis in HCC patients and it affects the malignant biological behavior of HCC through regulation of DNA methylation and EMT.

EXPERIMENTAL CELL RESEARCH (2022)

添加到收藏夹

Review Immunology

Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells

Benjamin Ruf et al.

Summary: Immune-based therapies, particularly immune checkpoint inhibitors, have shown significant improvements in the treatment of hepatocellular carcinoma (HCC), but durable responses are limited to a subset of patients. Understanding the immunologic mechanisms shaping the unique tumor microenvironment of liver cancer is crucial for developing effective therapeutic strategies. Current research focuses on targeting immune cells within the liver to enhance the therapeutic potential of immunotherapeutic agents.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Review Medicine, Research & Experimental

DNA methylation in lung cancer patients: Opening a window of life under precision medicine

Runzhang Liang et al.

Summary: DNA methylation, catalyzed by DNMT, plays a role in lung cancer pathogenesis and progression, with smoking influencing gene methylation status and increasing the risk of central lung cancer. It is crucial in the mechanisms of lung cancer, early diagnosis, and treatment, but faces challenges in clinical application due to limitations in methylation markers and sample tests. The future development of DNA methylation may need to focus on improving efficiency and sensitivity in liquid biopsy for lung cancer diagnosis.

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Review Oncology

Immune Checkpoint Inhibitors in the Treatment of HCC

Clelia Donisi et al.

Summary: Hepatocellular carcinoma (HCC) is typically inflammation-induced neoplasia, and immune therapies such as immune checkpoint inhibitors have shown promising results in various settings of HCC treatment. Anti-PD1 and anti-CTLA-4 antibodies have been successful in advanced HCC, leading to FDA approval in the second-line setting. The combination of locoregional therapies with immune checkpoint inhibitors is under study and may represent an effective strategy for HCC treatment.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Multimodal treatment of hepatocellular carcinoma

M. M. Kirstein et al.

INTERNIST (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma

Ann-Lii Cheng et al.

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Article Oncology

Prognostic role of tumor mutation burden in hepatocellular carcinoma after radical hepatectomy

Huayong Cai et al.

JOURNAL OF SURGICAL ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Implications of driver genes associated with a high tumor mutation burden identified using next-generation sequencing on immunotherapy in hepatocellular carcinoma

Li Li et al.

ONCOLOGY LETTERS (2020)

添加到收藏夹

Article Oncology

Tumor mutational burden is associated with poor outcomes in diffuse glioma

Lihong Wang et al.

BMC CANCER (2020)

添加到收藏夹

Review Cell Biology

The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma

Bart Vanderborght et al.

CELLS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

KLF2 inhibits TGF-β-mediated cancer cell motility in hepatocellular carcinoma

Yining Li et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2020)

添加到收藏夹

Article Oncology

P-229The value of alfa-fetoprotein and neutrophil/lymphocyte ratio (NLR) in the prognosis of patients with hepatocellular carcinoma

C Quintela et al.

ANNALS OF ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial

Eileen M. O'Reilly et al.

JAMA ONCOLOGY (2019)

添加到收藏夹

Article Cell Biology

Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironment

Wen-Hao Xu et al.

AGING-US (2019)

添加到收藏夹

Review Oncology

From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma

Yaojie Fu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Review Oncology

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

T. A. Chan et al.

ANNALS OF ONCOLOGY (2019)

添加到收藏夹

Article Oncology

High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy

Angela Mauriello et al.

CANCERS (2019)

添加到收藏夹

Article Immunology

Correlate tumor mutation burden with immune signatures in human cancers

Xiaosheng Wang et al.

BMC IMMUNOLOGY (2019)

添加到收藏夹

Review Pathology

Implications of the tumor immune microenvironment for staging and therapeutics

Janis M. Taube et al.

MODERN PATHOLOGY (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine

Naoto Fujiwara et al.

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Review Oncology

Immunotherapy of Hepatocellular Carcinoma

Bernd Heinrich et al.

ONCOLOGY RESEARCH AND TREATMENT (2018)

添加到收藏夹

Article Oncology

Monitoring immune checkpoint regulators as Predictive Biomarkers in hepatocellular carcinoma

Ritu Shrestha et al.

FRONTIERS IN ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Recurrence Patterns After Anatomic or Parenchyma-Sparing Liver Resection for Hepatocarcinoma in a Western Population of Cirrhotic Patients

Simone Famularo et al.

ANNALS OF SURGICAL ONCOLOGY (2018)

添加到收藏夹

Review Oncology

Molecular therapies and precision medicine for hepatocellular carcinoma

Josep M. Llovet et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

添加到收藏夹

Article Biochemical Research Methods

wTO: an R package for computing weighted topological overlap and a consensus network with integrated visualization tool

Deisy Morselli Gysi et al.

BMC BIOINFORMATICS (2018)

添加到收藏夹

Article Oncology

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

Jane Margetts et al.

BRITISH JOURNAL OF CANCER (2018)

添加到收藏夹

Article Oncology

Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival

Ahmedin Jemal et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)

添加到收藏夹

Article Medicine, General & Internal

First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer

D. P. Carbone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses

Valerie Chew et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

添加到收藏夹

Article Cell Biology

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

Pornpimol Charoentong et al.

CELL REPORTS (2017)

添加到收藏夹

Article Oncology

Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival

Ahmedin Jemal et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

Nadeem Riaz et al.

CELL (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

Willy Hugo et al.

CELL (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

Nicholas McGranahan et al.

SCIENCE (2016)

添加到收藏夹

Review Immunology

Immunoreceptors on neutrophils

Dieke J. van Rees et al.

SEMINARS IN IMMUNOLOGY (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Naiyer A. Rizvi et al.

SCIENCE (2015)

添加到收藏夹

Review Immunology

Neutrophils at work

William M. Nauseef et al.

NATURE IMMUNOLOGY (2014)

添加到收藏夹

Article Medicine, General & Internal

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

Alexandra Snyder et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Review Multidisciplinary Sciences

The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma

Pengyuan Yang et al.

NATIONAL SCIENCE REVIEW (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis

Ming Geng et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2012)

添加到收藏夹

Article Gastroenterology & Hepatology

Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma

Dong-Ming Kuang et al.

JOURNAL OF HEPATOLOGY (2011)

添加到收藏夹

Article Biochemical Research Methods

WGCNA: an R package for weighted correlation network analysis

Peter Langfelder et al.

BMC BIOINFORMATICS (2008)

添加到收藏夹

Article Mathematical & Computational Biology

Eigengene networks for studying the relationships between co-expression modules

Peter Langfelder et al.

BMC SYSTEMS BIOLOGY (2007)

添加到收藏夹

Article Gastroenterology & Hepatology

Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis

George N. Ioannou et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)

添加到收藏夹

Review Immunology

Neutrophils and immunity: challenges and opportunities

C Nathan

NATURE REVIEWS IMMUNOLOGY (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.